Enavatuzumab

Enavatuzumab
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T76865-5mg 5 mg

7 - 10 business days*

588.00€
 
Description: Enavatuzumab (PDL192, ABT-361) is a humanized IgG1 monoclonal antibody targeting the... more
Product information "Enavatuzumab"
Description: Enavatuzumab (PDL192, ABT-361) is a humanized IgG1 monoclonal antibody targeting the TWEAK receptor (TweakR), a protein involved in various cellular responses through its interaction with TWEAK (Fn14, TNFRSF12A). By engaging TweakR signaling and promoting antibody-dependent cell-mediated cytotoxicity (ADCC), enavatuzumab inhibits tumor growth and recruits myeloid effector cells to destroy tumor cells. It suppresses the proliferation of TweakR-positive cancer cell lines and tumorigenic models both in vitro and in vivo [1] [2].
Supplier: TargetMol
Supplier-Nr: T76865

Properties

Conjugate: No

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Enavatuzumab"
Write a review
or to review a product.
Viewed